beGalileo Deepens School Impact with Navneet, Expands Inclusive Learning Through Endeavor ELS Partnership
Bengaluru (Karnataka) [India], July 7: beGalileo, the Bangalore-based EdTech company and one of India's early pioneers in AI-driven education, has entered into a strategic partnership with Endeavor Extended Learning Services (ELS), an organization dedicated to serving children with special needs. This marks a significant step in beGalileo's mission to ensure that inclusive, quality education reaches every learner.
beGalileo offers highly effective programs in foundational Math, Coding, and English for both direct-to-child users and schools across curricula. With a presence in over 40 countries, the platform stands out in an EdTech sector often bogged down by skepticism, thanks to its strong learning outcomes and consistently positive customer feedback.
In parallel, beGalileo has also strengthened its collaboration with strategic investor Navneet Education. Navneet will now actively drive adoption of beGalileo's offerings through its nationwide sales, marketing, and implementation teams across CBSE and state board schools in India. The partnership with Endeavor adds a vital and compassionate dimension to this broader collaboration.
"In education, real innovation starts with empathy. Lean engineering and inclusion power a human-first, future-ready business," said Vivek Shaurya, Co-founder of beGalileo, reflecting on the company's values and its journey through turbulent times in EdTech.
For Endeavor, this partnership brings scale, reach, and access to a proven, adaptive platform designed to meet the diverse learning needs of neurodiverse children.
"At Endeavor, we believe that quality education must be accessible to all, and it must evolve to meet the learner. Our focus is to ensure every child has access to enriching cognitive and academic tools that respect their individual needs. This partnership with beGalileo is a key step in that journey," said Ms. Vidya Doraiswamy, Founder of Endeavor Extended Learning Services LLP.
"We started early--well before many current players--but our focus has always been on child equity and measurable learning outcomes. The partnership with Endeavor is a crucial step in addressing a space that needs urgent attention: education for children with special needs," added Avneet Makkar, CEO of beGalileo.
This expansion into inclusive education, combined with Navneet Education's institutional strength, is expected to significantly accelerate beGalileo's presence in the school ecosystem from the upcoming academic year.
"At Navneet, we are committed to nurturing meaningful innovation in education across India. Our partnership with beGalileo spans CBSE and state board schools, and we've already begun implementing Math Labs in some schools. We're proud that this innovation is now reaching children with special needs--ensuring no learner is left behind," said Harshil Gala, Head of Digital Tech Initiatives across Navneet Education (NSE: NAVNETEDUL).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
15 minutes ago
- Mint
Proxy adviser seeks update on ₹480 cr ESOP clawback from Rashmi Saluja
Mumbai: Five months after Dabur India Ltd chairman Mohit Burman took control of Religare Enterprises Ltd, a proxy advisory firm has sought an update on the issue of recovering shares of a subsidiary worth ₹ 480 crore from former Religare chair Rashmi Saluja. On Sunday, InGovern Research Services issued a note asking that Religare and its subsidiary, Care Health Insurance, provide details and an update on the employee share options awarded to Saluja. The Bengaluru-based proxy advisor also asked for the recovery of fees paid by Care Health to its former independent director, Pratap Venugopal, who provided legal opinion to the insurance firm. When contacted, Religare on Sunday said, 'Irdai issued an order holding the issuance of ESOPs to Dr Saluja illegal. Care Health Insurance Limited had filed an appeal before the Securities Appellate Tribunal (SAT) under instructions from Dr Saluja, who was then the non-executive chairperson of the board. Subsequent to Dr. Saluja's removal from the board, the board of directors of the company decided to withdraw the appeal. The said appeal before the SAT now stands withdrawn. We offer no further comments as these issues are being examined internally.' Saluja received ESOP grants representing about 2.5% of Care's share capital. More than four-fifths of the insurance firm's ESOPs were allotted to her. InGovern has also raised conflict of interest concerns about Venugopal, a senior advocate, counselling Care Insurance on the ESOPs, as he was also an independent director on the company's board. Venugopal was advising and approving Care's decisions on the ESOPs, as per InGovern. As per the proxy adviser's report, the Nomination and Remuneration Committee, which approves pay and stock options, also lacked independence as Venugopal was a part of it. The dual role of Venugopal was not clearly disclosed to shareholders, InGovern said. 'Venugopal played dual roles, as an advisor and an ID (independent director), in a critical matter like the issuance of ESOPs, especially after IRDAI had disapproved the issuance of ESOPs, yet the company relied on his legal opinion to proceed with it,' said Shriram Subramanian, managing director of InGovern. Such roles create potential conflict of interest in list companies if full disclosures are not made, he said. Mint could not immediately reach Venugopal for comment. Religare owns 62.91% of Care Health, while Kedaara Capital and Union Bank of India own 15.84% and 5.28%, respectively. Public shareholders own the remaining 16%. The issue raised by InGovern is about the grant of 22.7 million ESOPs by Care Health to Saluja, a non-executive director at the time, even after the Insurance Regulator and Development Authority of India rejected the proposal. Saluja had exercised 7.57 million of those options. In July 2024, IRDAI took action and imposed a ₹ 1 crore penalty on Care Health and ordered the company to buy back the 7.57 million exercised shares at ₹ 45.32 each within 30 days and cancel all unvested ESOPs within 15 days. IRDAI had found the grants in violation of Section 34A of the Insurance Act. Section 34A of the Indian Insurance Act, 1938 gives IRDAI the authority to approve the appointment, reappointment, termination, and remuneration of key managerial personnel in insurance companies. InGovern has now demanded a public disclosure of the minutes of the board and Nomination and Remuneration Committee meetings, legal opinions on ESOPs, full IRDAI correspondence, and conflict of interest declarations. At the regulatory level, the proxy adviser has called for a probe by the Securities and Exchange Board of India into disclosure lapses and a review by the ministry of corporate affairs into director roles and responsibilities.
Mint
15 minutes ago
- Mint
Proxy adviser seeks update on ₹480 cr ESOP clawback from Rashmi Saluja
Mumbai: Five months after Dabur India Ltd chairman Mohit Burman took control of Religare Enterprises Ltd, a proxy advisory firm has sought an update on the issue of recovering shares of a subsidiary worth ₹ 480 crore from former Religare chair Rashmi Saluja. On Sunday, InGovern Research Services issued a note asking that Religare and its subsidiary, Care Health Insurance, provide details and an update on the employee share options awarded to Saluja. The Bengaluru-based proxy advisor also asked for the recovery of fees paid by Care Health to its former independent director, Pratap Venugopal, who provided legal opinion to the insurance firm. When contacted, Religare on Sunday said, 'Irdai issued an order holding the issuance of ESOPs to Dr Saluja illegal. Care Health Insurance Limited had filed an appeal before the Securities Appellate Tribunal (SAT) under instructions from Dr Saluja, who was then the non-executive chairperson of the board. Subsequent to Dr. Saluja's removal from the board, the board of directors of the company decided to withdraw the appeal. The said appeal before the SAT now stands withdrawn. We offer no further comments as these issues are being examined internally.' Saluja received ESOP grants representing about 2.5% of Care's share capital. More than four-fifths of the insurance firm's ESOPs were allotted to her. InGovern has also raised conflict of interest concerns about Venugopal, a senior advocate, counselling Care Insurance on the ESOPs, as he was also an independent director on the company's board. Venugopal was advising and approving Care's decisions on the ESOPs, as per InGovern. As per the proxy adviser's report, the Nomination and Remuneration Committee, which approves pay and stock options, also lacked independence as Venugopal was a part of it. The dual role of Venugopal was not clearly disclosed to shareholders, InGovern said. 'Venugopal played dual roles, as an advisor and an ID (independent director), in a critical matter like the issuance of ESOPs, especially after IRDAI had disapproved the issuance of ESOPs, yet the company relied on his legal opinion to proceed with it,' said Shriram Subramanian, managing director of InGovern. Such roles create potential conflict of interest in list companies if full disclosures are not made, he said. Mint could not immediately reach Venugopal for comment. Religare owns 62.91% of Care Health, while Kedaara Capital and Union Bank of India own 15.84% and 5.28%, respectively. Public shareholders own the remaining 16%. The issue raised by InGovern is about the grant of 22.7 million ESOPs by Care Health to Saluja, a non-executive director at the time, even after the Insurance Regulator and Development Authority of India rejected the proposal. Saluja had exercised 7.57 million of those options. In July 2024, IRDAI took action and imposed a ₹ 1 crore penalty on Care Health and ordered the company to buy back the 7.57 million exercised shares at ₹ 45.32 each within 30 days and cancel all unvested ESOPs within 15 days. IRDAI had found the grants in violation of Section 34A of the Insurance Act. Section 34A of the Indian Insurance Act, 1938 gives IRDAI the authority to approve the appointment, reappointment, termination, and remuneration of key managerial personnel in insurance companies. InGovern has now demanded a public disclosure of the minutes of the board and Nomination and Remuneration Committee meetings, legal opinions on ESOPs, full IRDAI correspondence, and conflict of interest declarations.
India.com
36 minutes ago
- India.com
HP Board 10th & 12th Supplementary Exams schedule OUT on hpbose.org; check full schedule and timings
Exam- File image HP Board 10th & 12th Supplementary Exams 2025: The Himachal Pradesh Board of School Education (HPBOSE) has announced the supplementary/ compartment exam schedule for Classes 10 and 12 and as per the schedule, the board is going to conduct supplementary exams for students who did not pass the regular boards in one or two subjects. The HPBOSE has released the supplementary exam schedule for classes 10th and 12th along with other details regarding exam dates, application procedures, fees, and admit card access. The exams will be held from July 22nd to July 29th, 2025 in for 10th grade and from July 22nd to July 28th the 12th grade in the morning shift from 8:45AM to 12:00PM for both the classes. HP Board 10th Supplementary Exams Schedule 2025: When are exams? ⦁ Sanskrit, Punjabi, Urdu- July 22nd, 2025 ⦁ Hindi- July 23rd, 2025 ⦁ Social science- July 25th, 2025 ⦁ English- July 26th. 2025 ⦁ Political Science, Sociology- July 28th, 2025 HP Board 10th Supplementary Exams Schedule: Timing Exam Timings: From 8:45AM to 12:00PM HP Board 12th Supplementary Exams Schedule 2025 ⦁ English- July 22nd, 2025 ⦁ Accountancy, Chemistry, History- July 23rd, 2025 ⦁ Biology, Business Studies, Mathematics- July 25th, 2025 From 8:45AM to 12:00PM HP Board 10th & 12th Supplementary Exams 2025: Additional information Application forms were live from June 10th, and are open till June 26th without any late fee. Students have to pay about Rs. 700 per subject as an application fee. You can download the admit card and date-sheet for the supplementary exams at the official website of the HPBOSE at . Admit cards can be downloaded only after registration and confirmation of the supplementary exams under the 'student corner'. The exam will be held in a pen and paper (offline) medium, notably practical exams were already held in February hence no practical exams for supplementary candidates. Students must attain an aggregate of 33% overall to pass and the results are expected to be announced between August and October 2025. Interested students are advised to visit the official website for further information at .
